Goodwill and Intangible Assets (Tables)

6 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets

Schedule of changes in the carrying amount of goodwill

(In thousands)	Generic Pharmaceuticals
Balance at June 30, 2015	$	141
Goodwill acquired	240,575
Balance at December 31, 2015	$	240,716

Summary of intangible assets, net

	Weighted	Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	Avg. Life (Yrs.)	December 31, 2015		June 30, 2015		December 31, 2015			June 30, 2015			December 31, 2015		June 30, 2015
Definite-lived:
Cody Labs import license	15	$	582	$	582	$	(290	)	$	(269	)	$	292	$	313
KUPI product rights	15	409,000		—		(3,291		)	—			405,709		—
KUPI trade name	2	2,920		—		(148		)	—			2,772		—
KUPI other intangible assets	15	20,000		—		(135		)	—			19,865		—
Silarx product rights	15	10,000		10,000		(389		)	(56		)	9,611		9,944
Other product rights	14	653		653		(290		)	(269		)	363		384
Total definite-lived		$	443,155	$	11,235	$	(4,543	)	$	(594	)	$	438,612	$	10,641
Indefinite-lived:
KUPI in-process research and development	—	$	232,000	$	—	$	—		$	—		$	232,000	$	—
Silarx in-process research and development	—	18,000		18,000		—			—			18,000		18,000
Other product rights	—	449		449		—			—			449		449
Total indefinite-lived		250,449		18,449		—			—			250,449		18,449
Total intangible assets, net		$	693,604	$	29,684	$	(4,543	)	$	(594	)	$	689,061	$	29,090

Summary of future annual amortization expense

(In thousands) Fiscal Year Ending June 30,	Annual Amortization Expense
2016	$	14,877
2017	30,808
2018	29,930
2019	29,346
2020	29,338
Thereafter	304,313
	$	438,612